NTRA
NASDAQ · Biotechnology
Natera Inc
$310.67
-53.09 (-14.59%)
Analyst Consensus
Strong Buy
30
Analysts
Very High
Coverage
Price Target
Analyst Price Target
-54.0% upside
Low Target
$88.14
Average Target
$142.91
High Target
$188.78
Current Price
$310.67
Current
$310.67
$310.67
Target
$142.91
$142.91
$88.14
$142.91 avg
$188.78
Scenario Analysis
Bear Case
$88.14
-71.6%
Low target
Base Case
$142.91
-54.0%
Avg target
Bull Case
$188.78
+-39.2%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$437.41
-29.0% from high
52-Week Low
$181.00
+71.6% from low
50-Day SMA
$380.25
-18.3% vs SMA
200-Day SMA
$269.35
+15.3% vs SMA
RSI (14)
28.9
Oversold
Target vs 52W High
$142.91
-67.3% vs high
Next Earnings Report
Nov 11, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.30
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |